Alonso et al. suggest that, even in early tumour murine lung adenocarcinoma development, CD4+ T cells are driven to differentiate as Tregs rather that effector CD4+ T cells in the TDLN (Alonso et al., 2018). The gene discussed is CD4; the disease is neoplasm.